Option Investor
Market Updates

Getting more cautious on biotechs

Printer friendly version

I'm starting to see some biotech stocks begin violating their bullish support trends and some others getting close to violating these longer-term support trends. Last week we took a look at the Biotech Index (BTK.X) and felt a break below the $530 level could be trouble for bullish traders in the group. The BTK.X did muster a rally yesterday, but I'm monitoring some stocks that one by one may spell trouble.

Today, shares of Myriad Genetics (NASDAQ:MYGN) broke below its bullish support trend and gave a double-bottom sell signal at $45. Now I'm eyeballing shares of Genzyme Corporation (NASDAQ:GENZ) getting very close to breaking its bullish support trend and giving a triple-bottom sell signal.

Genzyme Corporation (GENZ) - $1 box

I don't think shorting/putting the biotechs is going to be a piece of cake for bears, but there are some negatives starting to develop in the group. Right now, shares of Genzyme (GENZ) are trading right on their 200-day MA of $53 and right on top of bullish support trend. A break below the $52 level could see the stock drop quickly to the $51-$50 level. If there's some type of "bad news" in the wings then the stock may be vulnerable to dropping right back into a base formed in October near $47.

For the BTK.X to break below its bullish support trend, you and I both know some biotech stocks have to also break down. With shares of Myriad Genetics (NASDAQ:MYGN) breaking its bullish support, a bearish trader may want to keep an eye on that stock and if she continues to weaken, then look to play shares of GENZ short/put on a break at $52.

I prefer to buy puts on biotech stocks and not short them outright. It's a personal preference in that I just don't like to take the risk that the biotech I'm short might announce some type of major breakthrough for the treatment of cancer or some other type of ailment. A trader/investor can limit their risk with a put option.

High Pole and Low Pole Warnings

In the Genzyme chart, I've highlighted a "high pole" warning. One subscriber asked for a definition of the high/low pole warnings or what they mean.

What we look for in supply/demand analysis is a major reversal or shift in supply/demand. By themselves they don't necessarily mean a lot, but we identify them as an ALERT to a potential change/shift in supply/demand. It's when a high pole warning is followed by a major break in trend or glaring sell signal that the "high pole" warning begins to have more credence and a trader that has identified the pole may have more conviction in their trading.

Conversely, the "low pole" warning gives hint that demand may be starting to outstrip supply and a stock may have achieved its bottom. Then, a bullish trader may have more conviction in bullish trades on breaks of triple-tops or breaks of downward trend to the upside.

Jeff Bailey
Senior Market Technician
Option Investor

Intraday Update Archives